aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of $504.63 million. The enterprise value is $436.96 million.

Market Cap	504.63M
Enterprise Value	436.96M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

aTyr Pharma has 97.99 million shares outstanding. The number of shares has increased by 31.11% in one year.

Current Share Class	97.99M
Shares Outstanding	97.99M
Shares Change (YoY)	+31.11%
Shares Change (QoQ)	+4.20%
Owned by Insiders (%)	2.06%
Owned by Institutions (%)	71.85%
Float	95.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.39
P/TBV Ratio	6.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.63, with a Debt / Equity ratio of 0.17.

Current Ratio	5.63
Quick Ratio	5.21
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -85.39% and return on invested capital (ROIC) is -47.95%.

Return on Equity (ROE)	-85.39%
Return on Assets (ROA)	-42.20%
Return on Invested Capital (ROIC)	-47.95%
Return on Capital Employed (ROCE)	-81.45%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +184.53% in the last 52 weeks. The beta is 0.95, so aTyr Pharma's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	+184.53%
50-Day Moving Average	5.36
200-Day Moving Average	3.92
Relative Strength Index (RSI)	47.77
Average Volume (20 Days)	6,116,364

Short Selling Information

The latest short interest is 25.60 million, so 26.12% of the outstanding shares have been sold short.

Short Interest	25.60M
Short Previous Month	20.38M
Short % of Shares Out	26.12%
Short % of Float	26.67%
Short Ratio (days to cover)	4.53

Income Statement

Revenue	n/a
Gross Profit	-54.23M
Operating Income	-70.05M
Pretax Income	-53.93M
Net Income	-66.64M
EBITDA	-69.36M
EBIT	-70.05M
Earnings Per Share (EPS)	-$0.80

Full Income Statement

Balance Sheet

The company has $80.35 million in cash and $12.68 million in debt, giving a net cash position of $67.67 million or $0.69 per share.

Cash & Cash Equivalents	80.35M
Total Debt	12.68M
Net Cash	67.67M
Net Cash Per Share	$0.69
Equity (Book Value)	74.66M
Book Value Per Share	0.81
Working Capital	71.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$55.60 million and capital expenditures -$49,000, giving a free cash flow of -$55.65 million.

Operating Cash Flow	-55.60M
Capital Expenditures	-49,000
Free Cash Flow	-55.65M
FCF Per Share	-$0.57

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.11%
Shareholder Yield	-31.11%
Earnings Yield	-13.21%
FCF Yield	-11.03%

Analyst Forecast

The average price target for aTyr Pharma is $20.20, which is 292.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.20
Price Target Difference	292.23%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	363.01%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 1, 2019. It was a reverse split with a ratio of 1:14.

Last Split Date	Jul 1, 2019
Split Type	Reverse
Split Ratio	1:14

Scores

aTyr Pharma has an Altman Z-Score of -3.48 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.48
Piotroski F-Score	1